13th August 2009, 04:25 PM | #11 | |
Member
Join Date: Dec 2004
Posts: 1,247
|
Quote:
Hi Miguel, As I noted above, it isn't a linear calculation, because diversity isn't evenly distributed among plant families, and because some groups of plants are far more likely to have potential drug properties than others. For example, the three most common plant families worldwide are the asters, orchids, and grasses. Of these, we're alive as a civilization because of the grasses (they're our main food source), and we get some interesting herbals (echinacea, wormwood, etc) from the Asters. Orchids? Pretty flowers and vanilla, yet they're the most diverse family in the tropical forests. It isn't that people don't use orchids for various things (like fiber or pretty flowers) but they aren't a drug source. Figs are another great example. I suspect there are some herbal uses that might even be useful for medicine. There are 800+ species of figs, and they're a keystone of life for tropical forests, because they fruit all year. Yet as far as I know, they all have much the same biochemistry, so no one is looking at figs as a source of medicine. That's another 800 species. I can keep on going until I run out of space, but the point is that, while most plants have some basic herbal use, often those uses are things we already know about. Finding a genuinely new drug is like finding a needle in a haystack. Those 1% that were already tested belonged to families that we knew contained drug compounds (like the nightshade family) or were used by indigenous people to do amazing things (like the curare plants or Davis' hallucinogens). Effectively, we've high-graded the forests for their easily accessible drug plants. While I'm sure that there's new undiscovered drugs out there, I don't think it's going to be easy to find, and the cost of finding those unknowns is what's keeping people from testing them. Hope this helps. It's nothing like a linear calculation. It's more like gold-mining. Best, F |
|
|
|